dcsimg
Global Offering

 

SciClone Pharmaceuticals (Holdings) Limited
 
 
COVER
IMPORTANT
EXPECTED TIMETABLE
CONTENTS
SUMMARY
DEFINITIONS
GLOSSARY OF TECHNICAL TERMS
FORWARD-LOOKING STATEMENTS
RISK FACTORS
WAIVERS FROM STRICT COMPLIANCE WITH THE LISTING RULES AND EXEMPTIONS FROM COMPLIANCE WITH THE COMPANIES (WINDING UP AND MISCELLANEOUS PROVISIONS) ORDINANCE
INFORMATION ABOUT THIS PROSPECTUS AND THE GLOBAL OFFERING
DIRECTORS AND PARTIES INVOLVED IN THE GLOBAL OFFERING
CORPORATE INFORMATION
INDUSTRY OVERVIEW
REGULATORY OVERVIEW
HISTORY, REORGANIZATION AND CORPORATE STRUCTURE
BUSINESS
RELATIONSHIP WITH OUR SINGLE LARGEST SHAREHOLDER
DIRECTORS AND SENIOR MANAGEMENT
SHARE CAPITAL
SUBSTANTIAL SHAREHOLDERS
FINANCIAL INFORMATION
FUTURE PLANS AND USE OF PROCEEDS
CORNERSTONE INVESTORS
UNDERWRITING
THE STRUCTURE OF THE GLOBAL OFFERING
HOW TO APPLY FOR HONG KONG OFFER SHARES
APPENDIX I - ACCOUNTANT'S REPORT
APPENDIX II - UNAUDITED PRO FORMA FINANCIAL INFORMATION
APPENDIX III - PROFIT ESTIMATE
APPENDIX IV - SUMMARY OF THE CONSTITUTION OF THE COMPANY AND CAYMAN COMPANY LAW
APPENDIX V - STATUTORY AND GENERAL INFORMATION
APPENDIX VI - DOCUMENTS DELIVERED TO THE REGISTRAR OF COMPANIES IN HONG KONG AND AVAILABLE FOR INSPECTION
BACK COVER